75 related articles for article (PubMed ID: 20555024)
21. Identification of genes associated with the corticotroph phenotype in bronchial carcinoid tumors.
Pascual-Le Tallec L; Dulmet E; Bertagna X; de Keyzer Y
J Clin Endocrinol Metab; 2002 Nov; 87(11):5015-22. PubMed ID: 12414866
[TBL] [Abstract][Full Text] [Related]
22. [So-called transitional or atypical carcinoids].
Bozadzhieva E; Topalov I; Georgiev Ch; Andreeva M; Paltonova E
Probl Endokrinol (Mosk); 1986; 32(1):40-1. PubMed ID: 3006018
[No Abstract] [Full Text] [Related]
23. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
Yoon HG; Wong J
Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
[TBL] [Abstract][Full Text] [Related]
24. The cellular and molecular basis of the ectopic ACTH syndrome.
White A; Clark AJ
Clin Endocrinol (Oxf); 1993 Aug; 39(2):131-41. PubMed ID: 8396510
[TBL] [Abstract][Full Text] [Related]
25. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
[TBL] [Abstract][Full Text] [Related]
26. Dopamine receptor expression and function in corticotroph ectopic tumors.
Pivonello R; Ferone D; de Herder WW; Faggiano A; Bodei L; de Krijger RR; Lombardi G; Colao A; Lamberts SW; Hofland LJ
J Clin Endocrinol Metab; 2007 Jan; 92(1):65-9. PubMed ID: 17032724
[TBL] [Abstract][Full Text] [Related]
27. β-Transducin repeat-containing protein 1 (β-TrCP1)-mediated silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) protein degradation promotes tumor necrosis factor α (TNFα)-induced inflammatory gene expression.
Hsu KS; Kao HY
J Biol Chem; 2013 Aug; 288(35):25375-25386. PubMed ID: 23861398
[TBL] [Abstract][Full Text] [Related]
28. ACTH-secreting thymic carcinoid associated with multiple endocrine neoplasia type 1.
Yano M; Fukai I; Kobayashi Y; Mizuno K; Konishi A; Haneda H; Suzuki E; Endo K; Fujii Y
Ann Thorac Surg; 2006 Jan; 81(1):366-8. PubMed ID: 16368411
[TBL] [Abstract][Full Text] [Related]
29. Altered corepressor SMRT expression and recruitment to target genes as a mechanism that change the response to androgens in prostate cancer progression.
Godoy AS; Sotomayor PC; Villagran M; Yacoub R; Montecinos VP; McNerney EM; Moser M; Foster BA; Onate SA
Biochem Biophys Res Commun; 2012 Jul; 423(3):564-70. PubMed ID: 22695118
[TBL] [Abstract][Full Text] [Related]
30. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
Suda T; Tozawa F; Dobashi I; Horiba N; Ohmori N; Yamakado M; Yamada M; Demura H
J Clin Invest; 1993 Dec; 92(6):2790-5. PubMed ID: 8254033
[TBL] [Abstract][Full Text] [Related]
31. Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence.
Smith CL; Migliaccio I; Chaubal V; Wu MF; Pace MC; Hartmaier R; Jiang S; Edwards DP; Gutiérrez MC; Hilsenbeck SG; Oesterreich S
Breast Cancer Res Treat; 2012 Nov; 136(1):253-65. PubMed ID: 23015261
[TBL] [Abstract][Full Text] [Related]
32. Modulation of transcriptional corepressor activity of prospero-related homeobox protein (Prox1) by SUMO modification.
Shan SF; Wang LF; Zhai JW; Qin Y; Ouyang HF; Kong YY; Liu J; Wang Y; Xie YH
FEBS Lett; 2008 Nov; 582(27):3723-8. PubMed ID: 18948102
[TBL] [Abstract][Full Text] [Related]
33. Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) regulates glucocorticoid action in adipocytes.
Emont MP; Mantis S; Kahn JH; Landeche M; Han X; Sargis RM; Cohen RN
Mol Cell Endocrinol; 2015 May; 407():52-6. PubMed ID: 25766503
[TBL] [Abstract][Full Text] [Related]
34. [Hormone production and abnormalities in gene expression in tumors].
Imura H; Nakai Y; Takahashi H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):721-30. PubMed ID: 3008663
[TBL] [Abstract][Full Text] [Related]
35. The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion.
Tsagarakis S; Tsigos C; Vasiliou V; Tsiotra P; Kaskarelis J; Sotiropoulou C; Raptis SA; Thalassinos N
J Clin Endocrinol Metab; 2002 Apr; 87(4):1646-53. PubMed ID: 11932296
[TBL] [Abstract][Full Text] [Related]
36. Neuroanatomical distribution and colocalisation of nuclear receptor corepressor (N-CoR) and silencing mediator of retinoid and thyroid receptors (SMRT) in rat brain.
van der Laan S; Lachize SB; Schouten TG; Vreugdenhil E; de Kloet ER; Meijer OC
Brain Res; 2005 Oct; 1059(2):113-21. PubMed ID: 16212947
[TBL] [Abstract][Full Text] [Related]
37. Thymic carcinoid with ectopic Cushing's disease.
Gupta V; Banerjee CK; Singh H; Suri S; Dash RJ
J Assoc Physicians India; 1990 Nov; 38(11):862-4. PubMed ID: 2079474
[No Abstract] [Full Text] [Related]
38. Nuclear translocation of MEK1 triggers a complex T cell response through the corepressor silencing mediator of retinoid and thyroid hormone receptor.
Guo L; Chen C; Liang Q; Karim MZ; Gorska MM; Alam R
J Immunol; 2013 Jan; 190(1):159-67. PubMed ID: 23225884
[TBL] [Abstract][Full Text] [Related]
39. SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1.
Cheng J; Wang D; Wang Z; Yeh ET
Mol Cell Biol; 2004 Jul; 24(13):6021-8. PubMed ID: 15199155
[TBL] [Abstract][Full Text] [Related]
40. The silencing mediator of retinoid and thyroid hormone receptors (SMRT) regulates adipose tissue accumulation and adipocyte insulin sensitivity in vivo.
Sutanto MM; Ferguson KK; Sakuma H; Ye H; Brady MJ; Cohen RN
J Biol Chem; 2010 Jun; 285(24):18485-95. PubMed ID: 20371609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
